am 580 has been researched along with sr 11217 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, SJ; Dawson, MI; Jetten, AM; Mills, KJ; Zhang, LX | 1 |
| Adamo, S; Avvisati, G; Benedetti, L; Diverio, D; Gambacorti-Passerini, C; Grignani, F; Jetten, AM; Levin, AA; Lo Coco, F; Nervi, C; Pelicci, PG; Scicchitano, BM | 1 |
2 other study(ies) available for am 580 and sr 11217
| Article | Year |
|---|---|
Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids.
Topics: Animals; Apoptosis; Benzoates; Bronchi; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Chromans; Chromatin; Enzyme Induction; Epithelium; Gene Expression; Humans; Luciferases; Lung Neoplasms; Rats; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Trachea; Transcription Factors; Transfection; Transglutaminases; Tumor Cells, Cultured | 1995 |
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Topics: Apoptosis; Benzoates; CD18 Antigens; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytosol; Drug Resistance, Neoplasm; Enzyme Induction; Fenretinide; Gene Expression Regulation, Leukemic; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Protein Multimerization; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transglutaminases; Translocation, Genetic; Tretinoin; Tumor Cells, Cultured | 1996 |